INDIANAPOLIS - JUNE 17: Researchers at Lilly Research Laboratories, shown here on June 17, 2014, developed basal insulin peglispro, a diabetes molecule undergoing Phase 3 clinical trials.

INDIANAPOLIS - JUNE 17:  Researchers at Lilly Research Laboratories, shown here on June 17, 2014, developed basal insulin peglispro, a diabetes molecule undergoing Phase 3 clinical trials.  - 29401819

類似的圖片

to-top-page